Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiate TransCon™ TLR7/8 Agonist Clinical Program

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing